A Drug-Coated Balloon Treatment for Urethral Stricture Disease: Three-Year Results from the ROBUST I Study

202219 citationsJournal Articlegold Open Access

Authors

Ramón Virasoro · Urology of Virginia

Jessica DeLong · Urology of Virginia

Rafael Estrella · Unión Médica Clínica Universitaria

Merycarla Pichardo

Ramón Rodríguez Lay

Gustavo Espino · Universidad Especializada de las Américas

Sean P. Elliott · University of Minnesota

Abstract

Symptomatic improvement after treatment with the Optilume DCB was maintained through 3 years in a population highly susceptible to recurrent urethral stricture disease. This minimally invasive therapy is safe with no negative impact on sexual function.

Topics & Keywords

Urological Disorders and Treatments Urinary and Genital Oncology Studies Urologic and reproductive health conditions

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Research and Reports in Urology

Volume Volume 14, pp. 177-183

DOI: 10.2147/rru.s359872

Field-Weighted Citation Impact: 4.00